Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-24

Clinical Trial Update: A Pilot Proof of Concept Study of the Effects of Administration of SCFA in Rheumatoid Arthritis (EASi-RA) [NA]

View source ↗

Summary

A completed pilot proof-of-concept trial assessing the effects of administering short-chain fatty acids in rheumatoid arthritis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Short-chain fatty acids (short-chain fatty acids)

Snippet

Sponsor: NYU Langone Health | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED